世界のデュタステリドAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Dutasteride API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1119 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はデュタステリドAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。デュタステリドAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（デュタステリド錠、デュタステリドカプセル、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・デュタステリドAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・デュタステリドAPIの種類別市場規模：純度≥98％、純度<98％ ・デュタステリドAPIの用途別市場規模：デュタステリド錠、デュタステリドカプセル、その他 ・北米のデュタステリドAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのデュタステリドAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのデュタステリドAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のデュタステリドAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのデュタステリドAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Gonane Pharma、Sterling Spa、Stermone Chemicals、Hubei Gedian Humanwell Pharmaceutical Co.,Ltd.、Gador SA、Cipla、Zhejiang Xianju Junye Pharmaceutical Co., Ltd.、Aspen Biopharma Labs、Chongqing Huapont Pharmaceutical、Swati Spentose Pvt.Ltd. ・デュタステリドAPIのバリューチェーン・販売チャネル分析 ・デュタステリドAPIの世界市場動向

Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.

Market Analysis and Insights: Global Dutasteride API Market
The global Dutasteride API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Dutasteride API Scope and Segment
Dutasteride API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dutasteride API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Dutasteride Tablets Dutasteride Capsules Others By Company Dr. Reddy’s Laboratories Ltd. Gonane Pharma Sterling Spa Stermone Chemicals Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Gador SA Cipla Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Aspen Biopharma Labs Chongqing Huapont Pharmaceutical Swati Spentose Pvt.Ltd. Production by Region Europe China India Japan Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Dutasteride API Product Introduction
1.2 Market by Type
1.2.1 Global Dutasteride API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Dutasteride API Market Size Growth Rate by Application 1.3.2 Dutasteride Tablets 1.3.3 Dutasteride Capsules 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Dutasteride API Production 2.1 Global Dutasteride API Production Capacity (2016-2027) 2.2 Global Dutasteride API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Dutasteride API Production by Region 2.3.1 Global Dutasteride API Historic Production by Region (2016-2021) 2.3.2 Global Dutasteride API Forecasted Production by Region (2022-2027) 2.4 Europe 2.5 China 2.6 India 2.7 Japan 3 Global Dutasteride API Sales in Volume & Value Estimates and Forecasts 3.1 Global Dutasteride API Sales Estimates and Forecasts 2016-2027 3.2 Global Dutasteride API Revenue Estimates and Forecasts 2016-2027 3.3 Global Dutasteride API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Dutasteride API Regions by Sales 3.4.1 Global Top Dutasteride API Regions by Sales (2016-2021) 3.4.2 Global Top Dutasteride API Regions by Sales (2022-2027) 3.5 Global Top Dutasteride API Regions by Revenue 3.5.1 Global Top Dutasteride API Regions by Revenue (2016-2021) 3.5.2 Global Top Dutasteride API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Dutasteride API Production Capacity by Manufacturers 4.2 Global Dutasteride API Sales by Manufacturers 4.2.1 Global Top Dutasteride API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Dutasteride API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Dutasteride API Sales in 2020 4.3 Global Dutasteride API Revenue by Manufacturers 4.3.1 Global Top Dutasteride API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Dutasteride API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Dutasteride API Revenue in 2020 4.4 Global Dutasteride API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Dutasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Dutasteride API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Dutasteride API Sales by Type 5.1.1 Global Dutasteride API Historical Sales by Type (2016-2021) 5.1.2 Global Dutasteride API Forecasted Sales by Type (2022-2027) 5.1.3 Global Dutasteride API Sales Market Share by Type (2016-2027) 5.2 Global Dutasteride API Revenue by Type 5.2.1 Global Dutasteride API Historical Revenue by Type (2016-2021) 5.2.2 Global Dutasteride API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Dutasteride API Revenue Market Share by Type (2016-2027) 5.3 Global Dutasteride API Price by Type 5.3.1 Global Dutasteride API Price by Type (2016-2021) 5.3.2 Global Dutasteride API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Dutasteride API Sales by Application 6.1.1 Global Dutasteride API Historical Sales by Application (2016-2021) 6.1.2 Global Dutasteride API Forecasted Sales by Application (2022-2027) 6.1.3 Global Dutasteride API Sales Market Share by Application (2016-2027) 6.2 Global Dutasteride API Revenue by Application 6.2.1 Global Dutasteride API Historical Revenue by Application (2016-2021) 6.2.2 Global Dutasteride API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Dutasteride API Revenue Market Share by Application (2016-2027) 6.3 Global Dutasteride API Price by Application 6.3.1 Global Dutasteride API Price by Application (2016-2021) 6.3.2 Global Dutasteride API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Dutasteride API Market Size by Type 7.1.1 North America Dutasteride API Sales by Type (2016-2027) 7.1.2 North America Dutasteride API Revenue by Type (2016-2027) 7.2 North America Dutasteride API Market Size by Application 7.2.1 North America Dutasteride API Sales by Application (2016-2027) 7.2.2 North America Dutasteride API Revenue by Application (2016-2027) 7.3 North America Dutasteride API Sales by Country 7.3.1 North America Dutasteride API Sales by Country (2016-2027) 7.3.2 North America Dutasteride API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Dutasteride API Market Size by Type 8.1.1 Europe Dutasteride API Sales by Type (2016-2027) 8.1.2 Europe Dutasteride API Revenue by Type (2016-2027) 8.2 Europe Dutasteride API Market Size by Application 8.2.1 Europe Dutasteride API Sales by Application (2016-2027) 8.2.2 Europe Dutasteride API Revenue by Application (2016-2027) 8.3 Europe Dutasteride API Sales by Country 8.3.1 Europe Dutasteride API Sales by Country (2016-2027) 8.3.2 Europe Dutasteride API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Dutasteride API Market Size by Type 9.1.1 Asia Pacific Dutasteride API Sales by Type (2016-2027) 9.1.2 Asia Pacific Dutasteride API Revenue by Type (2016-2027) 9.2 Asia Pacific Dutasteride API Market Size by Application 9.2.1 Asia Pacific Dutasteride API Sales by Application (2016-2027) 9.2.2 Asia Pacific Dutasteride API Revenue by Application (2016-2027) 9.3 Asia Pacific Dutasteride API Sales by Region 9.3.1 Asia Pacific Dutasteride API Sales by Region (2016-2027) 9.3.2 Asia Pacific Dutasteride API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Dutasteride API Market Size by Type 10.1.1 Latin America Dutasteride API Sales by Type (2016-2027) 10.1.2 Latin America Dutasteride API Revenue by Type (2016-2027) 10.2 Latin America Dutasteride API Market Size by Application 10.2.1 Latin America Dutasteride API Sales by Application (2016-2027) 10.2.2 Latin America Dutasteride API Revenue by Application (2016-2027) 10.3 Latin America Dutasteride API Sales by Country 10.3.1 Latin America Dutasteride API Sales by Country (2016-2027) 10.3.2 Latin America Dutasteride API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Dutasteride API Market Size by Type 11.1.1 Middle East and Africa Dutasteride API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Dutasteride API Revenue by Type (2016-2027) 11.2 Middle East and Africa Dutasteride API Market Size by Application 11.2.1 Middle East and Africa Dutasteride API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Dutasteride API Revenue by Application (2016-2027) 11.3 Middle East and Africa Dutasteride API Sales by Country 11.3.1 Middle East and Africa Dutasteride API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Dutasteride API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Dutasteride API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Gonane Pharma 12.2.1 Gonane Pharma Corporation Information 12.2.2 Gonane Pharma Overview 12.2.3 Gonane Pharma Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Gonane Pharma Dutasteride API Product Description 12.2.5 Gonane Pharma Recent Developments 12.3 Sterling Spa 12.3.1 Sterling Spa Corporation Information 12.3.2 Sterling Spa Overview 12.3.3 Sterling Spa Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Sterling Spa Dutasteride API Product Description 12.3.5 Sterling Spa Recent Developments 12.4 Stermone Chemicals 12.4.1 Stermone Chemicals Corporation Information 12.4.2 Stermone Chemicals Overview 12.4.3 Stermone Chemicals Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Stermone Chemicals Dutasteride API Product Description 12.4.5 Stermone Chemicals Recent Developments 12.5 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. 12.5.1 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Corporation Information 12.5.2 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Overview 12.5.3 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Product Description 12.5.5 Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Recent Developments 12.6 Gador SA 12.6.1 Gador SA Corporation Information 12.6.2 Gador SA Overview 12.6.3 Gador SA Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Gador SA Dutasteride API Product Description 12.6.5 Gador SA Recent Developments 12.7 Cipla 12.7.1 Cipla Corporation Information 12.7.2 Cipla Overview 12.7.3 Cipla Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Cipla Dutasteride API Product Description 12.7.5 Cipla Recent Developments 12.8 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. 12.8.1 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Corporation Information 12.8.2 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Overview 12.8.3 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Product Description 12.8.5 Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Recent Developments 12.9 Aspen Biopharma Labs 12.9.1 Aspen Biopharma Labs Corporation Information 12.9.2 Aspen Biopharma Labs Overview 12.9.3 Aspen Biopharma Labs Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Aspen Biopharma Labs Dutasteride API Product Description 12.9.5 Aspen Biopharma Labs Recent Developments 12.10 Chongqing Huapont Pharmaceutical 12.10.1 Chongqing Huapont Pharmaceutical Corporation Information 12.10.2 Chongqing Huapont Pharmaceutical Overview 12.10.3 Chongqing Huapont Pharmaceutical Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Chongqing Huapont Pharmaceutical Dutasteride API Product Description 12.10.5 Chongqing Huapont Pharmaceutical Recent Developments 12.11 Swati Spentose Pvt.Ltd. 12.11.1 Swati Spentose Pvt.Ltd. Corporation Information 12.11.2 Swati Spentose Pvt.Ltd. Overview 12.11.3 Swati Spentose Pvt.Ltd. Dutasteride API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Swati Spentose Pvt.Ltd. Dutasteride API Product Description 12.11.5 Swati Spentose Pvt.Ltd. Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Dutasteride API Industry Chain Analysis 13.2 Dutasteride API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Dutasteride API Production Mode & Process 13.4 Dutasteride API Sales and Marketing 13.4.1 Dutasteride API Sales Channels 13.4.2 Dutasteride API Distributors 13.5 Dutasteride API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Dutasteride API Industry Trends 14.2 Dutasteride API Market Drivers 14.3 Dutasteride API Market Challenges 14.4 Dutasteride API Market Restraints 15 Key Finding in The Global Dutasteride API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Dutasteride API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Dutasteride API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Dutasteride API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Dutasteride API Production by Region (2016-2021) & (Ton)
Table 7. Global Dutasteride API Production Market Share by Region (2016-2021)
Table 8. Global Dutasteride API Production by Region (2022-2027) & (Ton)
Table 9. Global Dutasteride API Production Market Share by Region (2022-2027)
Table 10. Global Dutasteride API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Dutasteride API Sales by Region (2016-2021) & (Ton)
Table 12. Global Dutasteride API Sales Market Share by Region (2016-2021)
Table 13. Global Dutasteride API Sales by Region (2022-2027) & (Ton)
Table 14. Global Dutasteride API Sales Market Share by Region (2022-2027)
Table 15. Global Dutasteride API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Dutasteride API Revenue Market Share by Region (2016-2021)
Table 17. Global Dutasteride API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Dutasteride API Revenue Market Share by Region (2022-2027)
Table 19. Global Dutasteride API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Dutasteride API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Dutasteride API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Dutasteride API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Dutasteride API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Dutasteride API Sales Share by Manufacturers (2016-2021)
Table 25. Global Dutasteride API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Dutasteride API Revenue Share by Manufacturers (2016-2021)
Table 27. Dutasteride API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Dutasteride API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Dutasteride API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride API as of 2020)
Table 30. Dutasteride API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Dutasteride API Product Offered
Table 32. Date of Manufacturers Enter into Dutasteride API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Dutasteride API Sales by Type (2016-2021) & (Ton)
Table 35. Global Dutasteride API Sales by Type (2022-2027) & (Ton)
Table 36. Global Dutasteride API Sales Share by Type (2016-2021)
Table 37. Global Dutasteride API Sales Share by Type (2022-2027)
Table 38. Global Dutasteride API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Dutasteride API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Dutasteride API Revenue Share by Type (2016-2021)
Table 41. Global Dutasteride API Revenue Share by Type (2022-2027)
Table 42. Dutasteride API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Dutasteride API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Dutasteride API Sales by Application (2016-2021) & (Ton)
Table 45. Global Dutasteride API Sales by Application (2022-2027) & (Ton)
Table 46. Global Dutasteride API Sales Share by Application (2016-2021)
Table 47. Global Dutasteride API Sales Share by Application (2022-2027)
Table 48. Global Dutasteride API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Dutasteride API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Dutasteride API Revenue Share by Application (2016-2021)
Table 51. Global Dutasteride API Revenue Share by Application (2022-2027)
Table 52. Dutasteride API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Dutasteride API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Dutasteride API Sales by Type (2016-2021) & (Ton)
Table 55. North America Dutasteride API Sales by Type (2022-2027) & (Ton)
Table 56. North America Dutasteride API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Dutasteride API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Dutasteride API Sales by Application (2016-2021) & (Ton)
Table 59. North America Dutasteride API Sales by Application (2022-2027) & (Ton)
Table 60. North America Dutasteride API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Dutasteride API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Dutasteride API Sales by Country (2016-2021) & (Ton)
Table 63. North America Dutasteride API Sales by Country (2022-2027) & (Ton)
Table 64. North America Dutasteride API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Dutasteride API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Dutasteride API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Dutasteride API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Dutasteride API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Dutasteride API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Dutasteride API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Dutasteride API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Dutasteride API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Dutasteride API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Dutasteride API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Dutasteride API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Dutasteride API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Dutasteride API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Dutasteride API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Dutasteride API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Dutasteride API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Dutasteride API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Dutasteride API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Dutasteride API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Dutasteride API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Dutasteride API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Dutasteride API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Dutasteride API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Dutasteride API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Dutasteride API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Dutasteride API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Dutasteride API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Dutasteride API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Dutasteride API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Dutasteride API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Dutasteride API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Dutasteride API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Dutasteride API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Dutasteride API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Dutasteride API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Dutasteride API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Dutasteride API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Dutasteride API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Dutasteride API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Dutasteride API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Dutasteride API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Dutasteride API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Dutasteride API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Dutasteride API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Dutasteride API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Dutasteride API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Dutasteride API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Dutasteride API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Dutasteride API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Dutasteride API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Gonane Pharma Corporation Information
Table 120. Gonane Pharma Description and Major Businesses
Table 121. Gonane Pharma Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Gonane Pharma Dutasteride API Product
Table 123. Gonane Pharma Recent Development
Table 124. Sterling Spa Corporation Information
Table 125. Sterling Spa Description and Major Businesses
Table 126. Sterling Spa Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Sterling Spa Dutasteride API Product
Table 128. Sterling Spa Recent Development
Table 129. Stermone Chemicals Corporation Information
Table 130. Stermone Chemicals Description and Major Businesses
Table 131. Stermone Chemicals Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Stermone Chemicals Dutasteride API Product
Table 133. Stermone Chemicals Recent Development
Table 134. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Corporation Information
Table 135. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 136. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Product
Table 138. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Recent Development
Table 139. Gador SA Corporation Information
Table 140. Gador SA Description and Major Businesses
Table 141. Gador SA Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Gador SA Dutasteride API Product
Table 143. Gador SA Recent Development
Table 144. Cipla Corporation Information
Table 145. Cipla Description and Major Businesses
Table 146. Cipla Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Cipla Dutasteride API Product
Table 148. Cipla Recent Development
Table 149. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Corporation Information
Table 150. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Description and Major Businesses
Table 151. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Product
Table 153. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Recent Development
Table 154. Aspen Biopharma Labs Corporation Information
Table 155. Aspen Biopharma Labs Description and Major Businesses
Table 156. Aspen Biopharma Labs Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Aspen Biopharma Labs Dutasteride API Product
Table 158. Aspen Biopharma Labs Recent Development
Table 159. Chongqing Huapont Pharmaceutical Corporation Information
Table 160. Chongqing Huapont Pharmaceutical Description and Major Businesses
Table 161. Chongqing Huapont Pharmaceutical Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Chongqing Huapont Pharmaceutical Dutasteride API Product
Table 163. Chongqing Huapont Pharmaceutical Recent Development
Table 164. Swati Spentose Pvt.Ltd. Corporation Information
Table 165. Swati Spentose Pvt.Ltd. Description and Major Businesses
Table 166. Swati Spentose Pvt.Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Swati Spentose Pvt.Ltd. Dutasteride API Product
Table 168. Swati Spentose Pvt.Ltd. Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Dutasteride API Distributors List
Table 172. Dutasteride API Customers List
Table 173. Dutasteride API Market Trends
Table 174. Dutasteride API Market Drivers
Table 175. Dutasteride API Market Challenges
Table 176. Dutasteride API Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Dutasteride API Product Picture
Figure 2. Global Dutasteride API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Dutasteride API Market Share by Application in 2020 & 2027
Figure 6. Dutasteride Tablets
Figure 7. Dutasteride Capsules
Figure 8. Others
Figure 9. Dutasteride API Report Years Considered
Figure 10. Global Dutasteride API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 11. Global Dutasteride API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 12. Global Dutasteride API Production Market Share by Region (2016-2021)
Figure 13. Global Dutasteride API Production Market Share by Region (2022-2027)
Figure 14. Dutasteride API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Dutasteride API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Dutasteride API Production Growth Rate in India (2016-2027) & (Ton)
Figure 17. Dutasteride API Production Growth Rate in Japan (2016-2027) & (Ton)
Figure 18. Global Dutasteride API Sales 2016-2027 (Ton)
Figure 19. Global Dutasteride API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Dutasteride API Revenue 2016-2027 (US$ Million)
Figure 21. Global Dutasteride API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 22. Global Dutasteride API Sales Market Share by Region (2016-2021)
Figure 23. Global Dutasteride API Sales Market Share by Region (2022-2027)
Figure 24. North America Dutasteride API Sales YoY (2016-2027) & (Ton)
Figure 25. North America Dutasteride API Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Europe Dutasteride API Sales YoY (2016-2027) & (Ton)
Figure 27. Europe Dutasteride API Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Asia-Pacific Dutasteride API Sales YoY (2016-2027) & (Ton)
Figure 29. Asia-Pacific Dutasteride API Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Latin America Dutasteride API Sales YoY (2016-2027) & (Ton)
Figure 31. Latin America Dutasteride API Revenue YoY (2016-2027) & (US$ Million)
Figure 32. Middle East & Africa Dutasteride API Sales YoY (2016-2027) & (Ton)
Figure 33. Middle East & Africa Dutasteride API Revenue YoY (2016-2027) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Dutasteride API Sales in 2020
Figure 35. The Top 10 and Top 5 Players Market Share by Dutasteride API Revenue in 2020
Figure 36. Dutasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 37. Global Dutasteride API Sales Market Share by Type (2016-2027)
Figure 38. Global Dutasteride API Revenue Market Share by Type (2016-2027)
Figure 39. Global Dutasteride API Sales Market Share by Application (2016-2027)
Figure 40. Global Dutasteride API Revenue Market Share by Application (2016-2027)
Figure 41. North America Dutasteride API Sales Market Share by Type (2016-2027)
Figure 42. North America Dutasteride API Revenue Market Share by Type (2016-2027)
Figure 43. North America Dutasteride API Sales Market Share by Application (2016-2027)
Figure 44. North America Dutasteride API Revenue Market Share by Application (2016-2027)
Figure 45. North America Dutasteride API Sales Share by Country (2016-2027)
Figure 46. North America Dutasteride API Revenue Share by Country (2016-2027)
Figure 47. United States Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 48. Canada Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 49. Europe Dutasteride API Sales Market Share by Type (2016-2027)
Figure 50. Europe Dutasteride API Revenue Market Share by Type (2016-2027)
Figure 51. Europe Dutasteride API Sales Market Share by Application (2016-2027)
Figure 52. Europe Dutasteride API Revenue Market Share by Application (2016-2027)
Figure 53. Europe Dutasteride API Sales Share by Country (2016-2027)
Figure 54. Europe Dutasteride API Revenue Share by Country (2016-2027)
Figure 55. Germany Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 56. France Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 57. U.K. Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 58. Italy Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 59. Russia Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 60. Asia Pacific Dutasteride API Sales Market Share by Type (2016-2027)
Figure 61. Asia Pacific Dutasteride API Revenue Market Share by Type (2016-2027)
Figure 62. Asia Pacific Dutasteride API Sales Market Share by Application (2016-2027)
Figure 63. Asia Pacific Dutasteride API Revenue Market Share by Application (2016-2027)
Figure 64. Asia Pacific Dutasteride API Sales Share by Region (2016-2027)
Figure 65. Asia Pacific Dutasteride API Revenue Share by Region (2016-2027)
Figure 66. China Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 67. Japan Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 68. South Korea Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 69. India Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 70. Australia Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 71. China Taiwan Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 72. Indonesia Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 73. Thailand Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 74. Malaysia Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 75. Latin America Dutasteride API Sales Market Share by Type (2016-2027)
Figure 76. Latin America Dutasteride API Revenue Market Share by Type (2016-2027)
Figure 77. Latin America Dutasteride API Sales Market Share by Application (2016-2027)
Figure 78. Latin America Dutasteride API Revenue Market Share by Application (2016-2027)
Figure 79. Latin America Dutasteride API Sales Share by Country (2016-2027)
Figure 80. Latin America Dutasteride API Revenue Share by Country (2016-2027)
Figure 81. Mexico Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 82. Brazil Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 83. Argentina Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 84. Middle East and Africa Dutasteride API Sales Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Dutasteride API Revenue Market Share by Type (2016-2027)
Figure 86. Middle East and Africa Dutasteride API Sales Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Dutasteride API Revenue Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Dutasteride API Sales Share by Country (2016-2027)
Figure 89. Middle East and Africa Dutasteride API Revenue Share by Country (2016-2027)
Figure 90. Turkey Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 91. Saudi Arabia Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 92. UAE Dutasteride API Revenue (2016-2027) & (US$ Million)
Figure 93. Dutasteride API Value Chain
Figure 94. Dutasteride API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

---